- Home
- Automated
- List of product information
- JYNNEOS SUSPENSION FOR INJECTION [SIN17067P]
JYNNEOS SUSPENSION FOR INJECTION [SIN17067P]
Active ingredients: JYNNEOS SUSPENSION FOR INJECTION
On this page
Product Info
JYNNEOS SUSPENSION FOR INJECTION
[SIN17067P]
Product information
Active Ingredient and Strength | MODIFIED VACCINIA ANKARA - BAVARIAN NORDIC (MVA-BN, LIVE, NON-REPLICATING) - 0.5 X 108 TO 3.95 X 108 INF. UNITS/DOSE |
Dosage Form | INJECTION, SUSPENSION |
Manufacturer and Country | BAVARIAN NORDIC A/S - DENMARK |
Registration Number | SIN17067P |
Licence Holder | AENON PHARMACEUTICALS SEA PTE. LTD. |
Forensic Classification | PRESCRIPTION ONLY MEDICINES |
Anatomical Therapeutic Chemical (ATC) code | J07BX01 |
1 INDICATIONS AND USAGE
JYNNEOS is a vaccine indicated for prevention of smallpox and mpox disease in adults 18 years of age and older determined to be at high risk for smallpox or mpox infection.
2 DOSAGE AND ADMINISTRATION
For subcutaneous injection only.
2.1 Dose and Schedule
Administer two doses (0.5 mL each) of JYNNEOS 4 weeks apart.
2.2 Preparation and Administration
Allow the vaccine to thaw and reach room temperature before use.
Once thawed, the vaccine may be kept at +2°C to +8°C for 4 weeks. Do not refreeze.
When thawed, JYNNEOS is a milky, light yellow to pale white colored suspension.
Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit.
If either of these conditions exists, the vaccine should not be administered.
Swirl the vial gently before use for at least 30 seconds. Withdraw a dose of 0.5 mL into a sterile syringe for injection.
Administer JYNNEOS by subcutaneous injection, preferably into the upper arm.
4 CONTRAINDICATIONS
Hypersensitivity to the active substance or to any of the excipients [see Description (8) – please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information] or trace residues (chicken protein, benzonase, gentamicin and ciprofloxacin).
